|
|
|
Diet for Asthma | Asthma and diet | Asthma cures | Diet for Asthma Sufferers | Anti inflammatory diet asthma Diet for asthma and eczema Diet can affect asthma in two ways. First, some foods can provoke asthma attacks by causing...
Aspirin kills 400% more people than H1N1 swine flu Natural News November 20, 2009 The CDC now reports that nearly 4,000 Americans have been killed by H1N1 swine flu. This number is supposed to sound big and scary, motivating...
From ANI Washington, Nov 24: A new American report suggests that clinical trial data had pointed out the association between the anti-inflammatory drug rofecoxib and cardiovascular risk nearly eight years ago. The report notes...
Stomach ulcers are troublesome and common as they affect up to 15 per cent of persons at least once in their lives.An ulcer is an open sore that may occur on the skin or on any of the mucous membranes of the body. An ulcer in...
Sinusitis patients life is regularly impacted by acute sinusitis or chronic sinusitis, Sinus Dynamics non-invasive nasal sinus treatment with Nasal nebulizer offers the convenience of treating all types of Sinusitis without any...
NEW YORK (Reuters) - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday.
Falls among elderly people are significantly associated with several classes of drugs, including sedatives often prescribed as sleep aids and medications used to treat mood disorders, according to a study led by a University of...
Posted on: Monday, 23 November 2009, 08:00 CST NASHVILLE, Tenn., Nov. 23 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced positive new top-line results from a study evaluating the safety...
Cumberland Pharmaceuticals Inc. todayannounced positive new top-line results from a study evaluating the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in hospitalized burn patients.
POZEN Inc. (NASDAQ: POZN) announced the start of enrollment for the phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325 mg of enteric coated aspirin and 40 mg of immediate release omeprazole, under...
